Safe Orthopaedics SA (EPA:ALSAF)

Market Cap	218.94K
Revenue (ttm)	5.81M
Net Income (ttm)	-205.44M
Shares Out	91.22K
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,252
Average Volume	26,237,223
Open	24.00
Previous Close	24.00
Day's Range	22.00 - 28.00
52-Week Range	2.00 - 2,400.00
Beta	0.33
RSI	41.43
Earnings Date	Jul 10, 2025

About Safe Orthopaedics

Safe Orthopaedics SA, a medical technology company, engages in the design, manufacturing, and marketing of sterile implants and single-use sterile surgical instruments for the treatment of spinal surgery. The company’s products portfolio includes SteriSpine PS, an all-round kit for the treatment of spinal fractures and degenerative pathologies, as well as essential kit for percutaneous treatment of spinal fractures; SteriSpine VA, a product platform for ready to use Kyphoplasty and Cement systems; SteriSpine LC, a ready to use instrumentation f...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2010
• Employees: 96
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALSAF

Financial Performance

In 2023, Safe Orthopaedics's revenue was 5.81 million, a decrease of -0.87% compared to the previous year's 5.86 million. Losses were -205.44 million, 2849.7% more than in 2022.